Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and deve...
Q1 2026
May 8, 2026
FY 2025
Dec 31, 2025
Q4 2025
FY 2024
Dec 31, 2024
Q4 2024